These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

586 related items for PubMed ID: 20884129

  • 1. Twice-weekly hypofractionated intensity-modulated radiotherapy for localized prostate cancer with low-risk nodal involvement: toxicity and outcome from a dose escalation pilot study.
    Zilli T, Jorcano S, Rouzaud M, Dipasquale G, Nouet P, Toscas JI, Casanova N, Wang H, Escudé L, Mollà M, Linero D, Weber DC, Miralbell R.
    Int J Radiat Oncol Biol Phys; 2011 Oct 01; 81(2):382-9. PubMed ID: 20884129
    [Abstract] [Full Text] [Related]

  • 2. Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicity.
    Quon H, Cheung PC, Loblaw DA, Morton G, Pang G, Szumacher E, Danjoux C, Choo R, Thomas G, Kiss A, Mamedov A, Deabreu A.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):898-905. PubMed ID: 21237581
    [Abstract] [Full Text] [Related]

  • 3. Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.
    Vesprini D, Sia M, Lockwood G, Moseley D, Rosewall T, Bayley A, Bristow R, Chung P, Ménard C, Milosevic M, Warde P, Catton C.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e415-21. PubMed ID: 21477939
    [Abstract] [Full Text] [Related]

  • 4. A Phase II trial of arc-based hypofractionated intensity-modulated radiotherapy in localized prostate cancer.
    Lock M, Best L, Wong E, Bauman G, D'Souza D, Venkatesan V, Sexton T, Ahmad B, Izawa J, Rodrigues G.
    Int J Radiat Oncol Biol Phys; 2011 Aug 01; 80(5):1306-15. PubMed ID: 20708855
    [Abstract] [Full Text] [Related]

  • 5. Acute toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated intensity-modulated radiotherapy.
    Pervez N, Small C, MacKenzie M, Yee D, Parliament M, Ghosh S, Mihai A, Amanie J, Murtha A, Field C, Murray D, Fallone G, Pearcey R.
    Int J Radiat Oncol Biol Phys; 2010 Jan 01; 76(1):57-64. PubMed ID: 19395192
    [Abstract] [Full Text] [Related]

  • 6. Moderate Hypofractionated Protracted Radiation Therapy and Dose Escalation for Prostate Cancer: Do Dose and Overall Treatment Time Matter?
    Kountouri M, Zilli T, Rouzaud M, Dubouloz A, Linero D, Escudé L, Jorcano S, Miralbell R.
    Int J Radiat Oncol Biol Phys; 2016 Feb 01; 94(2):272-9. PubMed ID: 26853336
    [Abstract] [Full Text] [Related]

  • 7. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.
    Pederson AW, Fricano J, Correa D, Pelizzari CA, Liauw SL.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):235-41. PubMed ID: 21163587
    [Abstract] [Full Text] [Related]

  • 8. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome.
    Zilli T, Jorcano S, Escudé L, Linero D, Rouzaud M, Dubouloz A, Miralbell R.
    Clin Oncol (R Coll Radiol); 2014 Jun 01; 26(6):316-22. PubMed ID: 24667210
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
    Deville C, Vapiwala N, Hwang WT, Lin H, Ad VB, Tochner Z, Both S.
    Int J Radiat Oncol Biol Phys; 2012 Mar 15; 82(4):1389-96. PubMed ID: 21664069
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial.
    Leite ETT, Ramos CCA, Ribeiro VAB, Salvajoli BP, Nahas WC, Salvajoli JV, Ynoe Moraes F.
    Int J Radiat Oncol Biol Phys; 2021 Apr 01; 109(5):1263-1270. PubMed ID: 33346091
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dose escalation study with two different hypofractionated intensity modulated radiotherapy techniques for localized prostate cancer: acute toxicity.
    Zilli T, Rouzaud M, Jorcano S, Dipasquale G, Nouet P, Toscas JI, Casanova N, Wang H, Escude L, Molla M, Linero D, Weber DC, Miralbell R.
    Technol Cancer Res Treat; 2010 Jun 01; 9(3):263-70. PubMed ID: 20441236
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.